aTyr Pharma (LIFE) Misses Q1 EPS by 11c

aTyr Pharma (NASDAQ: LIFE) reported Q1 EPS of ($0.44), $0.11 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential
• KeyBanc lowers Nike rating to Sector Weight on near-term uncertainty